Results Snapshot
Figures in Cr
Consolidated - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
No of Months
12
12
12
12
12
12
Operating Income
671.00
623.00
580.00
510.00
472.00
424.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
671.00
623.00
580.00
510.00
472.00
424.00
Expenditure (Ex Depriciation)
Stock Adjustments
-7.00
8.00
-5.00
-4.00
-13.00
3.00
Raw Materials Consumed
318.00
282.00
284.00
245.00
232.00
193.00
Power & Fuel Cost
11.00
11.00
11.00
10.00
8.00
7.00
Employee Cost
125.00
112.00
102.00
93.00
79.00
63.00
Operating Expenses
31.00
27.00
23.00
18.00
16.00
15.00
General and Administration Expenses
-1.00
-1.00
-1.00
-1.00
-1.00
-1.00
Selling and Distribution Expenses
35.00
28.00
23.00
18.00
16.00
24.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
4.00
3.00
3.00
2.00
2.00
1.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
573.00
521.00
480.00
421.00
376.00
337.00
Operating Profit (PBDIT) excl Other Income
97.00
101.00
99.00
89.00
95.00
87.00
Other Income
33.00
22.00
34.00
22.00
9.00
5.00
Operating Profit (PBDIT)
131.00
123.00
134.00
111.00
105.00
92.00
Interest
1.00
1.00
1.00
2.00
1.00
1.00
Profit before Depriciation and Tax
130.00
122.00
132.00
109.00
104.00
91.00
Depreciation
14.00
12.00
10.00
9.00
8.00
7.00
Profit Before Taxation & Exceptional Items
115.00
109.00
122.00
100.00
95.00
83.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
115.00
109.00
122.00
100.00
95.00
83.00
Provision for Tax
27.00
26.00
28.00
27.00
26.00
21.00
Profit After Tax
87.00
82.00
93.00
72.00
69.00
62.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
585.00
507.00
417.00
348.00
282.00
220.00
Profit Available for appropriations
673.00
589.00
510.00
421.00
351.00
282.00
Appropriations
673.00
589.00
510.00
421.00
351.00
282.00
Equity Dividend (%)
18.00%
18.00%
18.00%
15.00%
15.00%
15.00%
Earnings Per Share
43.88
41.11
46.58
36.40
34.63
31.08
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2026 is 7.67% vs 7.35% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2026 is -3.75% vs 1.59% in Mar 2025
Interest
YoY Growth in year ended Mar 2026 is -46.20% vs 28.53% in Mar 2025
Profit After Tax
YoY Growth in year ended Mar 2026 is 6.74% vs -11.74% in Mar 2025
Compare Profit and Loss Results of Lincoln Pharma.
Figures in Cr
consolidated - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
671.00
0
671.00
0%
Less :Inter divisional transfers
0.00
0
0.00
0%
Less: Excise
0.00
0
0.00
0%
Net Sales
671.00
0
671.00
0%
Expenditure (Ex Depriciation)
Stock Adjustments
-7.00
0
-7.00
0%
Raw Materials Consumed
318.00
0
318.00
0%
Power & Fuel Cost
11.00
0
11.00
0%
Employee Cost
125.00
0
125.00
0%
Operating Expenses
31.00
0
31.00
0%
General and Administration Expenses
-1.00
0
-1.00
0%
Selling and Distribution Expenses
35.00
0
35.00
0%
Cost of Software developments
0.00
0
0.00
0%
Miscellaneous Expenses
4.00
0
4.00
0%
Expenses Capitalised
0.00
0
0.00
0%
Total Expenditure
573.00
0
573.00
0%
Operating Profit (PBDIT) excl Other Income
97.00
0.00
97.00
0%
Other Income
33.00
0
33.00
0%
Operating Profit (PBDIT)
131.00
0
131.00
0%
Interest
1.00
0
1.00
0%
Profit before Depriciation and Tax
130.00
0
130.00
0%
Depreciation
14.00
0
14.00
0%
Profit Before Taxation & Exceptional Items
115.00
0
115.00
0%
Exceptional Income / Expenses
0.00
0
0.00
0%
Profit Before Tax
115.00
0
115.00
0%
Provision for Tax
27.00
0
27.00
0%
Profit After Tax
87.00
0
87.00
0%
Extraordinary Items
0.00
0
0.00
0%
Adj to Profit After Tax
0.00
0
0.00
0%
Profit Balance B/F
585.00
0
585.00
0%
Profit Available for appropriations
673.00
0
673.00
0%
Appropriations
673.00
0
673.00
0%
Equity Dividend (%)
18%
0%
18.00
Earnings Per Share
43.88
0
43.88
0%
Profit And Loss - Net Sales
Net Sales 671.03 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 7.67% vs 7.35% in Mar 2025
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 97.68 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -3.75% vs 1.59% in Mar 2025
Profit And Loss - Interest
Interest 1.01 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -46.20% vs 28.53% in Mar 2025
Profit And Loss - Profit After Tax
Profit After Tax 87.89 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 6.74% vs -11.74% in Mar 2025